Tuesday, September 22, 2020 2:49:19 AM
What I do know from the pharma investment world is that drug development from the pre-clinical stage is a long way from home.
Need to test efficacy in Murine (mouse) model, then a double-blind study (gold standard) in humans at some point.
Submission of testing protocols, methods, endpoints, dosing levels, ethical standards, etc.
All the while monitoring safety and effectiveness.
Many years and many millions of dollars.
Could be many years before FDA approval.
So.. where does it leave us?
Maybe PAOG is busy talking to the sister about how they merge?
Is it Oxi-Thyme?
LS5
FEATURED North Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia • Nov 4, 2024 9:00 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM
Rainmaker Worldwide Inc. to Assume Direct, Non-Dealer Sales of Miranda Water Technologies in U.S. and Mexico in First Quarter of 2025 • RAKR • Nov 4, 2024 8:31 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM